1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2017

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Nov 2 2017, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

Van Gelder, M., De Wreede, L. C., Bornhäuser, M., Niederwieser, D., Karas, M., Anderson, N. S., Gramatzki, M., Dreger, P., Michallet, M., Petersen, E., Bunjes, D., Potter, M., Beelen, D., Cornelissen, J. J., Yakoub-Agha, I., Russell, N. H., Finke, J., Schoemans, H., Vitek, A., Urbano-Ispízua & 31 others, Blaise, D., Volin, L., Chevallier, P., Caballero, D., Putter, H., Van Biezen, A., Henseler, A., Schönland, S., Kröger, N., Schetelig, J., Ehninger, G., Niederwieser, D., Jindra, P., Sengeloev, H., Gramatzki, M., Dreger, P., Petersen, E., Bunjes, D., Potter, M., Bacigalupo, A., Cortelezzi, A., Corradini, P., Ciceri, F., Olivieri, A., Martinelli, G., Alessandrino, E. P., Castagna, L., Cascavilla, N., Carella, A. M., Da Prada, G. A. & Chronic Malignancy Working Party, Mar 1 2017, In : Bone Marrow Transplantation. 52, 3, p. 372-380 9 p.

Research output: Contribution to journalArticle

Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: Case report and revision of literature

Sgherza, N., Abruzzese, E., Perla, G., Minervini, M. M., Chiello, V., Sciannamè, N. & Cascavilla, N., Jun 27 2017, In : Therapeutics and Clinical Risk Management. 13, p. 751-755 5 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04)

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., Aug 1 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04)

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., Aug 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., Aug 1 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., Aug 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Chiappella, A., Martelli, M., Angelucci, E., Brusamolino, E., Evangelista, A., Carella, A. M., Stelitano, C., Rossi, G., Balzarotti, M., Merli, F., Gaidano, G., Pavone, V., Rigacci, L., Zaja, F., D'Arco, A., Cascavilla, N., Russo, E., Castellino, A., Gotti, M., Congiu, A. G. & 6 others, Cabras, M. G., Tucci, A., Agostinelli, C., Ciccone, G., Pileri, S. A. & Vitolo, U., 2017, In : The Lancet Oncology. 18, 8, p. 1076-1088 13 p.

Research output: Contribution to journalArticle

2016

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A. A., Chanan-Khan, A. A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, C. A., Sonneveld, P. & Cascavilla, N., 2016, In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticle

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

Efficace, F., Mandelli, F., Fazi, P., Santoro, C., Gaidano, G., Cottone, F., Borchiellini, A., Carpenedo, M., Simula, M. P., Di Giacomo, V., Bergamaschi, M., Vincelli, I. D., Rodeghiero, F., Ruggeri, M., Scaramucci, L., Rambaldi, A., Cascavilla, N., Forghieri, F., Petrungaro, A., Ditonno, P. & 3 others, Caocci, G., Cirrincione, S. & Mazzucconi, M. G., Oct 1 2016, In : American Journal of Hematology. 91, 10, p. 995-1001 7 p.

Research output: Contribution to journalArticle

Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen

Musso, M., Messina, G., Di Renzo, N., Di Carlo, P., Vitolo, U., Scalone, R., Marcacci, G., Scalzulli, P. R., Moscato, T., Matera, R., Crescimanno, A., Santarone, S., Orciuolo, E., Merenda, A., Pavone, V., Pastore, D., Donnarumma, D., Carella, A. M., Ciochetto, C., Cascavilla, N. & 5 others, Mele, A., Lanza, F., Di Nicola, M., Bonizzoni, E. & Pinto, A., Jan 1 2016, In : British Journal of Haematology. 172, 1, p. 111-121 11 p.

Research output: Contribution to journalArticle

Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen

Musso, M., Messina, G., Di Renzo, N., Di Carlo, P., Vitolo, U., Scalone, R., Marcacci, G., Scalzulli, P. R., Moscato, T., Matera, R., Crescimanno, A., Santarone, S., Orciuolo, E., Merenda, A., Pavone, V., Pastore, D., Donnarumma, D., Carella, A. M., Ciochetto, C., Cascavilla, N. & 5 others, Mele, A., Lanza, F., Di Nicola, M., Bonizzoni, E. & Pinto, A., Jan 1 2016, In : British Journal of Haematology. 172, 1, p. 111-121 11 p.

Research output: Contribution to journalArticle

Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi

Merli, F., Luminari, S., Gobbi, P., Cascavilla, N., Mammi, C., Ilariucci, F., Stelitano, C., Musso, M., Baldini, L., Galimberti, S., Angrilli, F., Polimeno, G., Scalzulli, P. R., Ferrari, A., Marcheselli, L. & Federico, M., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1175-1181 7 p.

Research output: Contribution to journalArticle

Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi

Merli, F., Luminari, S., Gobbi, P., Cascavilla, N., Mammi, C., Ilariucci, F., Stelitano, C., Musso, M., Baldini, L., Galimberti, S., Angrilli, F., Polimeno, G., Scalzulli, P. R., Ferrari, A., Marcheselli, L. & Federico, M., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1175-1181 7 p.

Research output: Contribution to journalArticle

Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi

Merli, F., Luminari, S., Gobbi, P., Cascavilla, N., Mammi, C., Ilariucci, F., Stelitano, C., Musso, M., Baldini, L., Galimberti, S., Angrilli, F., Polimeno, G., Scalzulli, P. R., Ferrari, A., Marcheselli, L. & Federico, M., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1175-1181 7 p.

Research output: Contribution to journalArticle

Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi

Merli, F., Luminari, S., Gobbi, P. G., Cascavilla, N., Mammi, C., Ilariucci, F., Stelitano, C., Musso, M., Baldini, L., Galimberti, S., Angrilli, F., Polimeno, G., Scalzulli, P. R., Ferrari, A., Marcheselli, L. & Federico, M., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1175-1181 7 p.

Research output: Contribution to journalArticle

Ruxolitinib – better prognostic impact in low-intermediate 1 risk score: evaluation of the ‘rete ematologica pugliese’ (REP) in primary and secondary myelofibrosis

Mazza, P., Specchia, G., Di Renzo, N., Cascavilla, N., Tarantini, G., Capalbo, S. F., Urbano, T., Albano, F., Giovannni, R., Falcone, A. P., Santeramo, M. T., Spinosa, G. & Pisconti, S., May 27 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP)

Mazza, P., Minoia, C., Melpignano, A., Polimeno, G., Cascavilla, N., Di Renzo, N. & Specchia, G., Jan 1 2016, In : Annals of Hematology. 95, 2, p. 239-244 6 p.

Research output: Contribution to journalArticle

The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP)

Mazza, P., Minoia, C., Melpignano, A., Polimeno, G., Cascavilla, N., Di Renzo, N. & Specchia, G., Jan 1 2016, In : Annals of Hematology. 95, 2, p. 239-244 6 p.

Research output: Contribution to journalArticle

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms

Gugliotta, L., Iurlo, A., Gugliotta, G., Tieghi, A., Specchia, G., Gaidano, G., Scalzulli, P. R., Rumi, E., Dragani, A., Martinelli, V., Santoro, C., Randi, M. L., Tagariello, G., Candoni, A., Cattaneo, D., Ricco, A., Palmieri, R., Liberati, M., Langella, M., Rago, A. & 18 others, Bergamaschi, M., Monari, P., Miglio, R., Santoro, U., Cacciola, R. R., Rupoli, S., Mastrullo, L., Musto, P., Mazzucconi, M. G., Vignetti, M., Cortelezzi, A., Vianelli, N., Martino, B., De Stefano, V., Passamonti, F., Vannucchi, A. M., Melillo, L. & Cascavilla, N., Jul 1 2016, In : Leukemia Research. 46, p. 18-25 8 p.

Research output: Contribution to journalArticle

2015

Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients

Tadmor, T., Bari, A., Marcheselli, L., Sacchi, S., Aviv, A., Baldini, L., Gobbi, P. G., Pozzi, S., Ferri, P., Cox, M. C., Cascavilla, N., Iannitto, E., Federico, M. & Polliack, A., Jun 1 2015, In : Mayo Clinic Proceedings. 90, 6, p. 756-764 9 p.

Research output: Contribution to journalArticle

Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP)

Delia, M., Carluccio, P., Buquicchio, C., Vergine, C., Greco, G., Amurri, B., Melpignano, A., Melillo, L., Cascavilla, N., Guarini, A., Capalbo, S., Tarantini, G., Mazza, P., Pavone, V., Di Renzo, N. & Specchia, G., Apr 22 2015, In : Leukemia Research. 39, 11, p. 1166-1171 6 p.

Research output: Contribution to journalArticle

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study

Cascavilla, N., De Stefano, V., Pane, F., Pancrazzi, A., Iurlo, A., Gobbi, M., Palandri, F., Specchia, G., Marina Liberati, A., D’Adda, M., Gaidano, G., Fjerza, R., Achenbach, H., Smith, J., Wilde, P. & Vannucchi, A. M., May 18 2015, In : Drug Design, Development and Therapy. 9, p. 2687-2694 8 p.

Research output: Contribution to journalArticle

Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms' tumor 1 expression

Rossi, G., Carella, A. M., Minervini, M. M., di Nardo, F., Waure, C. D., Greco, M. M., Merla, E., Cillis, G. P. D., Di Renzo, N., Melpignano, A., Capalbo, S., Palumbo, G., Pisapia, G. & Cascavilla, N., Feb 1 2015, In : Leukemia Research. 39, 2, p. 138-143 6 p.

Research output: Contribution to journalArticle

Pre-Chemotherapy risk factors for invasive fungal diseases: Prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (seifem 2010-a multicenter study)

Caira, M., Candoni, A., Verga, L., Busca, A., Delia, M., Nosari, A., Caramatti, C., Castagnola, C., Cattaneo, C., Fanci, R., Chierichini, A., Melillo, L., Mitra, M. E., Picardi, M., Potenza, L., Salutari, P., Vianelli, N., Facchini, L., Cesarini, M., De Paolis, M. R. & 37 others, Di Blasi, R., Farina, F., Venditti, A., Ferrari, A., Garzia, M., Gasbarrino, C., Invernizzi, R., Lessi, F., Manna, A., Martino, B., Nadali, G., Offidani, M., Paris, L., Pavone, V., Rossi, G., Spadea, A., Specchia, G., Trecarichi, E. M., Vacca, A., Cesaro, S., Perriello, V., Aversa, F., Tumbarello, M., Pagano, L., Ragionieri, R., Orsola-Malpighi, O. S., Antoniazzi, F., Storti, S., Luppi, M., Pagliuca, S., Rossetti, E., Da Vià, M., Di Caprio, L., Majolino, I., Cascavilla, N., Turri, G. & Fanin, R., 2015, In : Haematologica. 100, 2, p. 284-292 9 p.

Research output: Contribution to journalArticle

"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"

Mele, G., Melpignano, A., Quarta, G., Palumbo, G., Capalbo, S., Falcone, A., Cascavilla, N., Palazzo, G., Mazza, P., Iannitto, E., Curci, P., Rizzi, R., Specchia, G., Rossini, B., Pavone, V., Ria, R., Vacca, A., Buquicchio, C., Tarantini, G., Minoia, C. & 5 others, Guarini, A., Ditonno, P., Polimeno, G., Reddiconto, G. & Di Renzo, N., Mar 1 2015, In : Leukemia Research. 39, 3, p. 279-283 5 p.

Research output: Contribution to journalArticle

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory Hodgkin's lymphoma: Experience with 27 patients

Zinzani, P. L., Vitolo, U., Viviani, S., Corradini, P., Motta, G., Tani, M., Cascavilla, N., Hohaus, S., Merli, F., Argnani, L. & Broccoli, A., Jul 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 7, p. 404-408 5 p.

Research output: Contribution to journalArticle

2014

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

Montillo, M., Tedeschi, A., Gaidano, G., Coscia, M., Petrizzi, V. B., Orlandi, E., Cascavilla, N., Ghia, P., Motta, M., Gallamini, A., Frustaci, A. M., Rossi, D., De Paoli, L., Nichelatti, M., Morra, E. & Massaia, M., Sep 1 2014, In : Haematologica. 99, 9

Research output: Contribution to journalArticle

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: A GIMEMA Multicenter Phase II Trial

Cortelezzi, A., Sciumè, M., Liberati, A. M., Vincenti, D., Cuneo, A., Reda, G., Laurenti, L., Zaja, F., Marasca, R., Chiarenza, A., Gritti, G., Orsucci, L., Storti, S., Angelucci, E., Cascavilla, N., Gobbi, M., Mauro, F. R., Morabito, F., Fabris, S., Piciocchi, A. & 6 others, Vignetti, M., Neri, A., Rossi, D., Giannarelli, D., Guarini, A. & Foà, R., 2014, In : Leukemia. 28, 3, p. 642-648 7 p.

Research output: Contribution to journalArticle

Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma

Lanza, F., Lemoli, R. M., Olivieri, A., Laszlo, D., Martino, M., Specchia, G., Pavone, V., Imola, M., Pasini, A., Milone, G., Scortechini, I., Todisco, E., Guggiari, E., Cascavilla, N., Martinelli, G., Rambaldi, A. & Bosi, A., Feb 2014, In : Transfusion. 54, 2, p. 331-339 9 p.

Research output: Contribution to journalArticle

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

Musto, P., Simeon, V., Martorelli, M. C., Petrucci, M. T., Cascavilla, N., Di Raimondo, F., Caravita, T., Morabito, F., Offidani, M., Olivieri, A., Benevolo, G., Mina, R., Guariglia, R., D'Arena, G., Mansueto, G., Filardi, N., Nobile, F., Levi, A., Falcone, A., Cavalli, M. & 10 others, Pietrantuono, G., Villani, O., Bringhen, S., Omedè, P., Lerose, R., Agnelli, L., Todoerti, K., Neri, A., Boccadoro, M. & Palumbo, A., 2014, In : Leukemia. 28, 1, p. 222-225 4 p.

Research output: Contribution to journalArticle

Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: A comparison between multiparameter flow cytometry and Wilm's tumor 1 levels

Rossi, G., Minervini, M. M., Melillo, L., Di Nardo, F., De Waure, C., Scalzulli, P. R., Perla, G., Valente, D., Sinisi, N. & Cascavilla, N., 2014, In : Annals of Hematology. 93, 7, p. 1149-1157 9 p.

Research output: Contribution to journalArticle

Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia

Bucaneve, G., Micozzi, A., Picardi, M., Ballanti, S., Cascavilla, N., Salutari, P., Specchia, G., Fanci, R., Luppi, M., Cudillo, L., Cantaffa, R., Milone, G., Bocchia, M., Martinelli, G., Offidani, M., Chierichini, A., Fabbiano, F., Quarta, G., Primon, V., Martino, B. & 6 others, Manna, A., Zuffa, E., Ferrari, A., Gentile, G., Foà, R. & Del Favero, A., May 10 2014, In : Journal of Clinical Oncology. 32, 14, p. 1463-1471 9 p.

Research output: Contribution to journalArticle

Safety and efficacy of 90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

Ibatici, A., Pica, G. M., Nati, S., Vitolo, U., Botto, B., Ciochetto, C., Petrini, M., Galimberti, S., Ciabatti, E., Orciuolo, E., Zinzani, P. L., Cascavilla, N., Guolo, F., Fraternali Orcioni, G. & Carella, A. M., Mar 2014, In : British Journal of Haematology. 164, 5, p. 710-716 7 p.

Research output: Contribution to journalArticle

2013

Cardiovascular events and intensity of treatment in polycythemia vera

Marchioli, R., Finazzi, G., Specchia, G., Cacciola, R., Cavazzina, R., Cilloni, D., De Stefano, V., Elli, E., Iurlo, A., Latagliata, R., Lunghi, F., Lunghi, M., Marfisi, R. M., Musto, P., Masciulli, A., Musolino, C., Cascavilla, N., Quarta, G., Randi, M. L., Rapezzi, D. & 12 others, Ruggeri, M., Rumi, E., Scortechini, A. R., Santini, S., Scarano, M., Siragusa, S., Spadea, A., Tieghi, A., Angelucci, E., Visani, G., Vannucchi, A. M. & Barbui, T., Jan 3 2013, In : New England Journal of Medicine. 368, 1, p. 22-33 12 p.

Research output: Contribution to journalArticle

CD117-CD15 in acute myeloid leukemia: No role as LAIP in the study of minimal residual disease

Rossi, G., Nomdedéu Guinot, J. F., Fontana, A., Minervini, M. M., García-Dabrio, M. C. & Cascavilla, N., Feb 2013, In : European Journal of Haematology. 90, 2, p. 171-174 4 p.

Research output: Contribution to journalArticle

Minimal residual disease after allogeneic stem cell transplant: A comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemia

Rossi, G., Carella, A. M., Minervini, M. M., Savino, L., Fontana, A., Pellegrini, F., Greco, M. M., Merla, E., Quarta, G., Loseto, G., Capalbo, S., Palumbo, G. & Cascavilla, N., Dec 2013, In : Leukemia and Lymphoma. 54, 12, p. 2660-2666 7 p.

Research output: Contribution to journalArticle

2012

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study

Rigacci, L., Puccini, B., Dodero, A., Iacopino, P., Castagna, L., Bramanti, S., Ciceri, F., Fanin, R., Rambaldi, A., Falda, M., Milone, G., Guidi, S., Martelli, M. F., Mazza, P., Oneto, R., Bosi, A., Foà, R., Leoni, P., Liso, V., Pioltelli, P. & 33 others, Cascavilla, N., Scimé, R., Rizzoli, V., Ballestrero, A., Raimondi, R., Arcese, W., Musso, M., Benedetti, F., Guerrasio, A., Majolino, I., Lambertenghi, D. G., Baccarani, M., Bacigalupo, A., Petrini, M., Carella, A. M., Levis, A., La Nasa, G., Merli, F., Narni, F., Lauria, F., Cortelazzo, S., Longinotti, M., Olivieri, A., Favre, C., Cantore, N., Da Prada, G. A., Selleri, C., Bruno, B., Giovanni, M., Leone, G., Di Bartolomeo, P., Morandi, S. & Vallisa, D., Jun 2012, In : Annals of Hematology. 91, 6, p. 931-939 9 p.

Research output: Contribution to journalArticle

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

Cortelezzi, A., Gritti, G., Laurenti, L., Cuneo, A., Ciolli, S., di Renzo, N., Musto, P., Mauro, F. R., Cascavilla, N., Falchi, L., Zallio, F., Callea, V., Maura, F., Martinelli, S., Piciocchi, A., Reda, G. & Foà, R., Feb 2012, In : British Journal of Haematology. 156, 4, p. 481-489 9 p.

Research output: Contribution to journalArticle

Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets

Rossi, G., Minervini, M. M., Carella, A. M., de Waure, C., di Nardo, F., Melillo, L., D'Arena, G., Zini, G. & Cascavilla, N., Apr 2012, In : Leukemia Research. 36, 4, p. 401-406 6 p.

Research output: Contribution to journalArticle

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jȩdrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., May 10 2012, In : New England Journal of Medicine. 366, 19, p. 1759-1769 11 p.

Research output: Contribution to journalArticle

Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study

Oliva, E. N., Piccin, A., Mazzucconi, M. G., Morra, E., Recine, U., Pogliani, E. M., Pane, F., Gobbi, M., Gugliotta, L., Krampera, M., Cascavilla, N., Cacciola, R., Cacciola, E., Fioritoni, G., Fanin, R., Liberati, A. M., Angelucci, E. & Tura, S., Apr 2012, In : Annals of Hematology. 91, 4, p. 527-532 6 p.

Research output: Contribution to journalArticle

2011

Active caspase-3 detection to evaluate apoptosis induced by Verbena officinalis essential oil and citral in chronic lymphocytic leukaemia cells

de Martino, L., Arena, G. D., Minervini, M. M., Deaglio, S., Sinisi, N. P., Cascavilla, N. & de Feo, V., Sep 2011, In : Brazilian Journal of Pharmacognosy. 21, 5, p. 869-873 5 p.

Research output: Contribution to journalArticle

Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients

Bassetti, M., Aversa, F., Ballerini, F., Benedetti, F., Busca, A., Cascavilla, N., Concia, E., Tendas, A., Di Raimondo, F., Mazza, P., Nosari, A. M. & Rossi, G., 2011, In : Clinical Drug Investigation. 31, 11, p. 745-758 14 p.

Research output: Contribution to journalArticle

Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma

De Luisi, A., Ferrucci, A., Coluccia, A. M. L., Ria, R., Moschetta, M., De Luca, E., Pieroni, L., Maffia, M., Urbani, A., Di Pietro, G., Guarini, A., Ranieri, G., Ditonno, P., Berardi, S., Caivano, A., Basile, A., Cascavilla, N., Capalbo, S., Quarta, G., Dammacco, F. & 2 others, Ribatti, D. & Vacca, A., Apr 1 2011, In : Clinical Cancer Research. 17, 7, p. 1935-1946 12 p.

Research output: Contribution to journalArticle

Monoclonal antibodies to treat graft-versus-host disease

Carella, A. M., D'Arena, G. & Cascavilla, N., Jun 2011, In : Mini-Reviews in Medicinal Chemistry. 11, 6, p. 473-479 7 p.

Research output: Contribution to journalArticle

Non-pegylated liposomal doxorubicin (Myocet®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma

Dell'Olio, M., Potito Scalzulli, R., Sanpaolo, G., Nobile, M., Saverio Mantuano, F., La Sala, A., D'Arena, G., Miraglia, E., Lucania, A., Mastrullo, L. & Nicola, C., Jul 2011, In : Leukemia and Lymphoma. 52, 7, p. 1222-1229 8 p.

Research output: Contribution to journalArticle